000 01037 a2200325 4500
005 20250513113947.0
264 0 _c19970624
008 199706s 0 0 eng d
022 _a1040-872X
040 _aNLM
_beng
_cNLM
100 1 _aSeetalarom, K
245 0 0 _aTaxanes in ovarian cancer treatment.
_h[electronic resource]
260 _bCurrent opinion in obstetrics & gynecology
_cFeb 1997
300 _a14-20 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Agents, Phytogenic
_xtherapeutic use
650 0 4 _aDocetaxel
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aOvarian Neoplasms
_xmortality
650 0 4 _aPaclitaxel
_xanalogs & derivatives
650 0 4 _aSurvival Rate
650 0 4 _aTaxoids
650 0 4 _aTreatment Outcome
700 1 _aKudelka, A P
700 1 _aVerschraegen, C F
700 1 _aKavanagh, J J
773 0 _tCurrent opinion in obstetrics & gynecology
_gvol. 9
_gno. 1
_gp. 14-20
999 _c9074005
_d9074005